The 4th IVD Distribution Enterprise Forum of China Concluded with Success

After the 20th National Congress of China, in response to new policies, new directions and new mechanisms, the "4th IVD Distribution Enterprise Forum of China" was successfully held on October 25, 2022, at the conference center of Primus Hotel Nanchang International Expo City.

The forum theme is "New Potential Energy, New Values, New Development", focused on the development trend of circulation enterprises, with tens of thousands of online live broadcast viewers.

Professor Song Haibo, Associate Dean of Shanghai Academy of Experimental Medicine, Vice Chairman of National Association of Health Industry and Enterprises Management, Chairman of China Association of In Vitro Diagnostics, Chief Editor of VIEW Journal by WILEY and Mr. Jiquan, president of Zybio, etc. presented the forum. During the forum, many chairmen of well-known in vitro diagnostic listing companies, industry experts, and senior investment bank managers made wonderful theme speech regarding to the topics of how to run a distribution company, regulations on supervision and administration of medical equipment, business analysis and financing of IVD distribution enterprise… 

The meeting further discussed the future direction of enterprises in the distribution field under the support of new policies. The distribution field is a bridge linking the upper and lower streams, following the country's policies and attention to investment, focusing on the keywords of the 13th and 14th Five-Year Plans, volume procurement, normalization of medical device centralized procurement, import substitution support for domestic production, etc., what do these keywords mean for circulation enterprises,

Multidimensional discussions took place around these topics in this forum.

The increase in market concentration is the future development trend, and with the introduction of policies, Chinese IVD enterprises have moved towards intensive service providers. The core values of circulation enterprises are technical services, operation management, coordinated distribution, capital flow, and market support. Distribution and service are indispensable and important forces in the health industry.

At this moment of the new policy environment and the normalization of the epidemic, distribution enterprises should pay attention to standardized service standards, meet the requirements of various authorities. Use digital tools and collaborative platforms to carry out sales and operation management more effectively. Deeply aware that these trends are unstoppable, accelerate transformation and innovation, highlight the value of enterprises, and achieve service technology integration.